Research expertise
Solid dosage forms, Powder technology, Particle engineering (micro/nano), Dissolution enhancement, Dry powder inhalers, Oral delivery, Controlled release formulations, Pharmaceutical formulations, Solid state analysis, Transdermal delivery
Biography
Ali obtained his pharmacy degree (PharmD) in 1989 from Tabriz School of Pharmacy, Iran. He completed his PhD on Pharmaceutical Technology at John Moores University, Liverpool in 1996 and has been a qualified pharmacist since 1989.He held a lectureship (1997 - 2001), and senior lectureship (2001 - 2003) at the School of Pharmacy, Tabriz University of Medical Sciences. During this period he was head of postgraduate studies and also vice-dean for research for a period of 4 years in Tabriz School of Pharmacy. In 2003 he was appointed as lecturer of pharmaceutics at King’s College London, Department of Pharmacy. He worked as professor of Pharmaceutical Technology at Tabriz School of Pharmacy prior to this appointment as senior lecturer of Pharmaceutics at Medway School of Pharmacy. Ali has been promoted to Reader in 2013 and now he is a Professor in Pharmaceutics and Drug Delivery at The University of Sussex, School of Life Sciences. He has supervised over 120 Mpharm, PharmD, MSc project students and 15 PhD postgraduate students at several institutions in various fields of pharmaceutical technology. At the present he is working on particle engineering, dissolution enhancement techniques and controlled release formulations. He is a regular reviewer for many international pharmacy journals and editorial board of several journals in pharmaceutical sciences. Ali has published a significant number of manuscripts (over 170 research articles in peer-reviewed international pharmacy journals ) on various fields of pharmaceutics, mainly, tableting, particle engineering, inhalation, skin delivery and controlled-release formulations. In addition, he published 5 book chapters (2010-2015) and a book on pulmonary drug delivery. He holds H-index of 34 with over 3000 citations till December 2015.
